BYLVAY Hard capsule Ref.[27935] Active ingredients: Odevixibat

Source: European Medicines Agency (EU)  Revision Year: 2024  Publisher: Ipsen Pharma, 65 quai Georges Gorse, 92100 Boulogne-Billancourt, France

Product name and form

Bylvay 200 micrograms hard capsules.

Bylvay 400 micrograms hard capsules.

Bylvay 600 micrograms hard capsules.

Bylvay 1 200 micrograms hard capsules.

Pharmaceutical Form

Hard capsule.

Bylvay 200 mcg hard capsules: Size 0 capsule (21.7 mm × 7.64 mm) with ivory opaque cap and white opaque body; imprinted “A200” with black ink.

Bylvay 400 mcg hard capsules: Size 3 capsule (15.9 mm × 5.82 mm) with orange opaque cap and white opaque body; imprinted “A400” with black ink.

Bylvay 600 mcg hard capsules: Size 0 capsule (21.7 mm × 7.64 mm) with ivory opaque cap and body; imprinted “A600” with black ink.

Bylvay 1200 mcg hard capsules: Size 3 capsule (15.9 mm × 5.82 mm) with orange opaque cap and body; imprinted “A1200” with black ink.

Qualitative and quantitative composition

Bylvay 200 mcg hard capsules: Each hard capsule contains odevixibat sesquihydrate equivalent to 200 micrograms odevixibat.

Bylvay 400 mcg hard capsules: Each hard capsule contains odevixibat sesquihydrate equivalent to 400 micrograms odevixibat.

Bylvay 600 mcg hard capsules: Each hard capsule contains odevixibat sesquihydrate equivalent to 600 micrograms odevixibat.

Bylvay 1200 mcg hard capsules: Each hard capsule contains odevixibat sesquihydrate equivalent to 1 200 micrograms odevixibat.

For the full list of excipients, see section 6.1.

Active Ingredient Description
Odevixibat

Odevixibat is a reversible, potent, selective inhibitor of the ileal bile acid transporter (IBAT). Odevixibat acts locally in the distal ileum to decrease the reuptake of bile acids and increase the clearance of bile acids through the colon, reducing the concentration of bile acids in the serum. The extent of reduction of serum bile acids does not correlate with systemic PK.

List of Excipients

Capsule content:

Microcrystalline cellulose
Hypromellose Ph.Eur

Capsule shell:

Bylvay 200 mcg and 600 mcg hard capsules:

Hypromellose
Titanium dioxide (E171)
Yellow iron oxide (E172)

Bylvay 400 mcg and 1200 mcg hard capsules:

Hypromellose
Titanium dioxide (E171)
Yellow iron oxide (E172)
Red iron oxide (E172)

Printing ink:

Shellac Ph.Eur
Propylene glycol
Black iron oxide (E172)

Pack sizes and marketing

High-density polyethylene (HDPE) bottle with a tamper evident, child resistant polypropylene closure.

Pack size: 30 hard capsules.

Marketing authorization holder

Ipsen Pharma, 65 quai Georges Gorse, 92100 Boulogne-Billancourt, France

Marketing authorization dates and numbers

EU/1/21/1566/001
EU/1/21/1566/002
EU/1/21/1566/003
EU/1/21/1566/004

Date of first authorisation: 16 July 2021

Drugs

Drug Countries
BYLVAY Austria, Estonia, Spain, France, Croatia, Ireland, Israel, Italy, Lithuania, Poland, Romania

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.